A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta ...

Her article, subtitled "He's Not Bad, He's Not Mad, He's Just Young!” helped set a path for family therapy using the old systems idea that it is easier to change the music than to change the dancers.

CBT has long been considered a gold-standard treatment for depression—but does it still hold up? A new review of over 60 recent trials suggests its effects remain strong.

The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how ...